CSTL
Castle Biosciences
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- A prospective validation study in JAAD showed that Castle Biosciences’ AdvanceAD-Tx™ test identified patients more likely to achieve faster and deeper responses to JAK inhibitors in moderate-to-severe atopic dermatitisFeb 20, 2026
- Meta-analysis confirms TissueCypher® outperforms traditional pathology in identifying esophageal cancer riskDec 12, 2025
- FDA grants Breakthrough Device designation to Castle Biosciences' DecisionDx®-Melanoma testJul 23, 2025